The Experimental Drug Development Centre (EDDC), Singapore’s national platform for drug discovery and development, is pleased to announce that the Phase 1 trial for EBC-129...
Sepsis, a life-threatening complication of infections, poses a severe threat to cancer patients, whose compromised immune systems make them highly susceptible. In a study published...
Recently, a research group led by Dr. JIANG Yanyi from Hefei Institutes of Physical Science of Chinese Academy of Sciences, along with Dr. LIN Dechen's...
Lisa Rotenstein, MD, of the Department of Medicine at Brigham and Women’s Hospital, is the lead author of a new study published in JAMA Network...
Vaccinia viruses are therapeutic tools with different biomedical applications depending on the susceptibility characteristics. For example, the strain called MVA (modified vaccinia Ankara), which is...
Previous studies on the function of glycosaminoglycans have primarily focused on improving host physiological indices. However, little attention has been paid to the material basis...
Hepatocellular carcinoma (HCC) represents a significant global health burden as one of the most common malignancies in individuals with chronic liver disease or cirrhosis. This...
